Al18F-NOTA-FAPI PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Al18F-NOTA-FAPI PET/CT, covering 2024-03-29 to 2024-03-29. Get the full timeline:
Most recent: Clinical Trial Update: Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins [Phase 2, Phase 3]